Recent studies have demonstrated that lower baseline IGF1 levels predict the subsequent development of impaired glucose tolerance (IGT), type 2 diabetes, cardiovascular disease and a worsening state of insulin-resistance. Here, IGF1 is linked to cardiovascular disorder.